Boehringer Ingelheim and Mirati Therapeutics, Inc. entered a clinical collaboration to evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor,...
Read moreiBio, Inc., a biotech innovator and biologics contract manufacturing organization, announced that it has selected IBIO-201, its LicKM™-ubunit vaccine, as...
Read moreIndia’s top drug regulator– Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to...
Read moreThe Diosna Dierks & Söhne GmbH recently opened the “Diosna ProcessLab” located in Osnabrück, Germany. The lab, which was completed...
Read moreOncoImmune, Inc. announced the completion of a $56 million financing in Series B equity co-led by HM Capital and a...
Read moreSharp – part of UDG Healthcare plc, a global leader in contract packaging clinical supply services, has launched a new...
Read moreCancer drugs firm Blueprint Medicines has gained a second US approval, with its Gavreto (pralsetinib) daily pill that targets non-small...
Read moreRoche announced U.S. FDA approval for the expanded use of CINtec® PLUS Cytology, the first triage test based on biomarker...
Read moreValneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs, announced a vaccine partnership with...
Read moreMerck is making a major investment into Bothwell, Washington-based Seattle Genetics with two strategic oncology deals. Seattle Genetics’ shares rocketed...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.